Exact Mass: 567.1999
Exact Mass Matches: 567.1999
Found 293 metabolites which its exact mass value is equals to given mass value 567.1999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neoacrimarine H
Neoacrimarine H is found in citrus. Neoacrimarine H is an alkaloid from the roots of Citrus paradisi (grapefruit). Alkaloid from the roots of Citrus paradisi (grapefruit). Neoacrimarine H is found in citrus.
Met Kinase Inhibitor
Hydroxy Bosentan
[4-((1Z)-2-(Acetylamino)-3-{[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]amino}-3-oxoprop-1-enyl)-2-formylphenyl]acetic acid
GalNAcGlcNAcThrNAc
[Chemical] Source; sea squirt H-antigen (limited periodate oxide)
N-(2,5,12-dimethoxy-3,11,16-trimethyl-1,4,10,13-tetraoxo-1,5,6,7,9,10,13,14,14a,15-decahydro-4H-6,15-epiazano-benzo[4,5]azocino[1,2-b]isoquinolin-9-ylmethyl)-2-oxo-propionamide|Saframycin C
O-beta-D-galactopyranosyl-(1-->4)-O-beta-D-galactopyranosyl-(1-->3)-O-beta-D-arabinofuranosyl-(1-->1)-cytosine
Ala Glu Trp Tyr
Ala Glu Tyr Trp
Ala Trp Glu Tyr
Ala Trp Tyr Glu
Ala Tyr Glu Trp
Ala Tyr Trp Glu
Cys Glu Met Trp
Cys Glu Trp Met
Cys Met Glu Trp
Cys Met Trp Glu
Cys Pro Trp Tyr
Cys Pro Tyr Trp
Cys Trp Glu Met
Cys Trp Met Glu
Cys Trp Pro Tyr
Cys Trp Tyr Pro
Cys Tyr Pro Trp
Cys Tyr Trp Pro
Asp Asp Arg Tyr
Asp Asp Tyr Arg
Asp Phe Met Arg
Asp Phe Arg Met
Asp Phe Thr Trp
Asp Phe Trp Thr
Asp Met Phe Arg
Asp Met Arg Phe
Asp Arg Asp Tyr
Asp Arg Phe Met
Asp Arg Met Phe
Asp Arg Tyr Asp
Asp Thr Phe Trp
Asp Thr Trp Phe
Asp Trp Phe Thr
Asp Trp Thr Phe
Asp Tyr Asp Arg
Asp Tyr Arg Asp
Glu Ala Trp Tyr
Glu Ala Tyr Trp
Glu Cys Met Trp
Glu Cys Trp Met
Glu Glu Gln Tyr
Glu Glu Tyr Gln
Glu Phe Ser Trp
Glu Phe Trp Ser
Glu His Pro Trp
Glu His Trp Pro
Glu Met Cys Trp
Glu Met Trp Cys
Glu Pro His Trp
Glu Pro Trp His
Glu Gln Glu Tyr
Glu Gln Tyr Glu
Glu Ser Phe Trp
Glu Ser Trp Phe
Glu Trp Ala Tyr
Glu Trp Cys Met
Glu Trp Phe Ser
Glu Trp His Pro
Glu Trp Met Cys
Glu Trp Pro His
Glu Trp Ser Phe
Glu Trp Tyr Ala
Glu Tyr Ala Trp
Glu Tyr Glu Gln
Glu Tyr Gln Glu
Glu Tyr Trp Ala
Phe Asp Met Arg
Phe Asp Arg Met
Phe Asp Thr Trp
Phe Asp Trp Thr
Phe Glu Ser Trp
Phe Glu Trp Ser
Phe Met Asp Arg
Phe Met Arg Asp
Phe Arg Asp Met
Phe Arg Met Asp
Phe Ser Glu Trp
Phe Ser Trp Glu
Phe Thr Asp Trp
Phe Thr Trp Asp
Phe Trp Asp Thr
Phe Trp Glu Ser
Phe Trp Ser Glu
Phe Trp Thr Asp
His Glu Pro Trp
His Glu Trp Pro
His Pro Glu Trp
His Pro Trp Glu
His Trp Glu Pro
His Trp Pro Glu
Met Cys Glu Trp
Met Cys Trp Glu
Met Asp Phe Arg
Met Asp Arg Phe
Met Glu Cys Trp
Met Glu Trp Cys
Met Phe Asp Arg
Met Phe Arg Asp
Met Met Met Arg
Met Met Arg Met
Met Met Thr Trp
Met Met Trp Thr
Met Arg Asp Phe
Met Arg Phe Asp
Met Arg Met Met
Met Thr Met Trp
Met Thr Trp Met
Met Trp Cys Glu
Met Trp Glu Cys
Met Trp Met Thr
Met Trp Thr Met
Pro Cys Trp Tyr
Pro Cys Tyr Trp
Pro Glu His Trp
Pro Glu Trp His
Pro His Glu Trp
Pro His Trp Glu
Pro Trp Cys Tyr
Pro Trp Glu His
Pro Trp His Glu
Pro Trp Tyr Cys
Pro Tyr Cys Trp
Pro Tyr Trp Cys
Gln Glu Glu Tyr
Gln Glu Tyr Glu
Gln Tyr Glu Glu
Arg Asp Asp Tyr
Arg Asp Phe Met
Arg Asp Met Phe
Arg Asp Tyr Asp
Arg Phe Asp Met
Arg Phe Met Asp
Arg Met Asp Phe
Arg Met Phe Asp
Arg Met Met Met
Arg Tyr Asp Asp
Ser Glu Phe Trp
Ser Glu Trp Phe
Ser Phe Glu Trp
Ser Phe Trp Glu
Ser Trp Glu Phe
Ser Trp Phe Glu
Thr Asp Phe Trp
Thr Asp Trp Phe
Thr Phe Asp Trp
Thr Phe Trp Asp
Thr Met Met Trp
Thr Met Trp Met
Thr Trp Asp Phe
Thr Trp Phe Asp
Thr Trp Met Met
Trp Ala Glu Tyr
Trp Ala Tyr Glu
Trp Cys Glu Met
Trp Cys Met Glu
Trp Cys Pro Tyr
Trp Cys Tyr Pro
Trp Asp Phe Thr
Trp Asp Thr Phe
Trp Glu Ala Tyr
Trp Glu Cys Met
Trp Glu Phe Ser
Trp Glu His Pro
Trp Glu Met Cys
Trp Glu Pro His
Trp Glu Ser Phe
Trp Glu Tyr Ala
Trp Phe Asp Thr
Trp Phe Glu Ser
Trp Phe Ser Glu
Trp Phe Thr Asp
Trp His Glu Pro
Trp His Pro Glu
Trp Met Cys Glu
Trp Met Glu Cys
Trp Met Met Thr
Trp Met Thr Met
Trp Pro Cys Tyr
Trp Pro Glu His
Trp Pro His Glu
Trp Pro Tyr Cys
Trp Ser Glu Phe
Trp Ser Phe Glu
Trp Thr Asp Phe
Trp Thr Phe Asp
Trp Thr Met Met
Trp Tyr Ala Glu
Trp Tyr Cys Pro
Trp Tyr Glu Ala
Trp Tyr Pro Cys
Tyr Ala Glu Trp
Tyr Ala Trp Glu
Tyr Cys Pro Trp
Tyr Cys Trp Pro
Tyr Asp Asp Arg
Tyr Asp Arg Asp
Tyr Glu Ala Trp
Tyr Glu Glu Gln
Tyr Glu Gln Glu
Tyr Glu Trp Ala
Tyr Pro Cys Trp
Tyr Pro Trp Cys
Tyr Gln Glu Glu
Tyr Arg Asp Asp
Tyr Trp Ala Glu
Tyr Trp Cys Pro
Tyr Trp Glu Ala
Tyr Trp Pro Cys
Neoacrimarine H
5-DMT-N6-Me-2-dA
5'-O-DMT-N6-Me-2'-dA is a nucleoside with protective and modification effects.
azepan-2-one,1,3-diisocyanato-2-methylbenzene,2,4-diisocyanato-1-methylbenzene,2-(2-hydroxyethoxy)ethanol
Mibefradil dihydrochloride
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Phenyl 3-azido-3-deoxy-2,4,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
(11bR)-2,6-Bis(3,5-dimethylphenyl)-N,N-dimethyl-dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin-4-amine
Phenyl 4-azido-4-deoxy-2,3,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor
Exatecan mesilate hydrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors
[4-((1Z)-2-(Acetylamino)-3-{[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]amino}-3-oxoprop-1-enyl)-2-formylphenyl]acetic acid
(3E)-N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide
2-[4-[(Z)-2-acetamido-3-oxo-3-[[2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
3-{4-[(2-ethoxy-7-{[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl}-1H-benzimidazol-1-yl)methyl]biphenyl-2-yl}-5-oxo-1,2,4-oxadiazol-4-ide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-oxobutyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[3-hydroxy-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbutan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
(5,9-Diacetyloxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-6-yl)methyl acetate
N-[(2S,3R,4R,5R,6R)-2-[(2S,3R,4S,5S,6R)-5-acetamido-6-[(2S,3R)-3-acetamido-4-hydroxy-1-oxobutan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
GDC-6036-NH
GDC-6036-NH is from patent WO2020097537A2, and a precursor of compound 17 a/b. Compound 17 a/b is a RAS inhibitor and can be used in cancer research[1].
6'-o-β-d-glucopyranosylmorroniside
{"Ingredient_id": "HBIN012643","Ingredient_name": "6'-o-\u03b2-d-glucopyranosylmorroniside","Alias": "NA","Ingredient_formula": "C23H35O16","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8684","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}